Document is current
Any future updates will be listed below
-
Authors
Blacksmith, Matthew S.
Nguyen, Anthony K.
Moran, John V.
Kidd, Jeffrey M.
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences of the National Institutes of Health (T32GM149391)
National Institute of General Medical Sciences of the National Institutes of Health (GM060518)
National Institute of General Medical Sciences of the National Institutes of Health (GM140135)
- License Information
-
More Information
Article History
Received: 10 September 2025
Accepted: 12 March 2026
First Online: 20 March 2026
Declarations
:
: Not applicable
: J.V.M. is an inventor on patent US6150160, was a paid consultant for Gilead Sciences, serves on the scientific advisory board of Tessera Therapeutics Inc. (where he is paid as a consultant and has equity options), and has licensed reagents to Merck Pharmaceutical. He also previously served on the American Society of Human Genetics Board of Directors. The other authors do not declare competing interests.
